![]() |
市場調查報告書
商品編碼
1828170
2025年全球智慧注射器市場報告Smart Syringe Global Market Report 2025 |
||||||
近年來,智慧注射器市場規模強勁成長,從2024年的111.4億美元成長到2025年的121.5億美元,複合年成長率為9.0%。預測期內的成長歸因於藥品安全需求、血源性疾病流行、法規遵從性、全球疫苗接種計劃以及醫療保健意識的不斷提高。
預計未來幾年智慧注射器市場將快速成長,到2029年將達到190.2億美元,複合年成長率為11.9%。預測期內的成長主要受以下因素驅動:全球疫苗接種工作、用藥錯誤預防、慢性病增多、家庭醫療保健的擴展以及政府醫療保健計劃。預測期內的主要趨勢包括合作與夥伴關係、監管回應、疫苗接種計劃的採用、對永續材料的關注以及新興市場的擴張。
智慧注射器是整合先進技術的尖端醫療設備,旨在提升注射的安全性、準確性和效率。這些創新注射器有效解決了針刺傷、用藥錯誤以及血液感染疾病傳播等關鍵問題,顯著提高了病患和醫護人員的安全。
智慧注射器的主要類別包括自動停用注射器、主動安全注射器和被動安全注射器。自動停用注射器經過特別設計,可防止單次注射後重複使用。這些注射器廣泛應用於疫苗宣傳活動,一次使用後即可自動鎖定,確保安全無污染的給藥。這種多功能解決方案適用於包括兒童和成人在內的各個群體,並可用於藥物輸送、疫苗接種和檢體採樣。自動拆卸注射器應用於各種行業,包括醫院、健康維護組織 (HMO)、糖尿病患者照護、家庭醫學和精神病學。
2025年美國關稅的大幅上調及其引發的貿易摩擦,對醫療設備產業產生了重大影響,尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制價格上漲,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 最新報告系列之一,提供智慧注射器市場統計數據,例如全球市場規模、區域佔有率、競爭對手的智慧注射器市場佔有率、詳細的智慧注射器細分市場、市場趨勢、商業機會以及在智慧注射器行業取得成功所需的其他數據。這份智慧注射器市場研究報告對該行業的現狀和未來情況進行了詳細分析,為您提供所需的一切全面觀點。
未來五年的預測成長率為11.9%,較我們先前對該市場的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響將透過對主要由法國和丹麥供應的劑量控制微處理器和自動覆蓋機制徵收關稅直接影響美國,並可能增加安全藥物傳輸系統的成本。由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響,這種影響可能會更加廣泛。
預計未來幾年,不斷成長的醫療支出將推動智慧注射器市場的成長。醫療支出代表國家、組織和個人投入醫療服務和產品的總資源,通常以貨幣量化。支出的成長受到多種因素的影響,包括人口老化、慢性病的流行、醫療技術的進步以及消費者對優質照護不斷提高的期望。智慧注射器市場正在透過提供創新解決方案來應對這種成長,這些解決方案可增強病患安全性、提高手術效率並降低與傳統注射器併發症相關的醫療成本。例如,非營利加拿大衛生資訊研究所預測,到 2023 年 11 月,加拿大的醫療總支出將達到 3,440 億美元,年增 2.8%。因此,醫療支出的成長正在推動智慧注射器市場的擴張。
預計血源性疾病的日益普及將在未來幾年推動智慧注射器市場的成長。血液傳染疾病是由病原體引起的感染疾病,透過接觸受感染的血液或體液傳播。智慧注射器配備了一次性使用後自動停止推桿的裝置,可降低意外針刺的風險,並提供一種有效的工具來對抗這些疾病。例如,2024 年 4 月,美國公共衛生機構疾病管制與預防中心 (CDC) 報告稱,2022 年有 2,126 例急性乙型肝炎病例。這比 2021 年報告的 2,045 例有所增加,估計感染率約為 13,300。因此,血源性疾病的興起正在刺激智慧注射器市場的擴張。
隨著領先公司推出安全注射器等新產品,智慧注射器市場正在經歷日益成長的產品創新,以增強患者安全性,最大限度地降低針刺傷風險,並提高手術效率。安全注射器經過專門設計,旨在降低針刺傷的可能性並防止注射器重複使用。例如,2024年4月,印度醫療設備公司印度斯坦注射器和醫療器材公司(Hindustan Syringes and Medical Devices)推出了Dispojekt注射器,這是一款旨在增強醫療環境安全性的安全注射器。 Dispojekt採用透明的單手安全機制,可減少意外針刺傷(NSI),這是醫護人員血液傳染疾病的常見原因。注射器還配有模壓塑膠安全防護罩,可防止使用過程中血液飛濺,為患者和醫護人員創造更安全的環境。透過解決關鍵的安全和感染控制問題,Dispojekt體現了HMD對品質和創新的承諾,並支持印度成為全球醫療製造領導者的目標。
智慧注射器市場前沿的企業正積極投資技術進步,並融入近距離場通訊(NFC) 技術等創新技術,以提升競爭優勢。 NFC 是一種近距離無線通訊技術,可促進裝置之間的非接觸式資料交換。法國醫療設備製造商 NP Plastibell 於 2022 年 5 月推出預填充智慧注射器,體現了這一趨勢。這款智慧注射器內建 NFC 晶片,可將重要的用藥資訊傳達給醫生和患者。 NFC 晶片儲存藥品名稱、劑量、有效期限和批號等關鍵訊息,方便透過智慧型手機和其他支援 NFC 的裝置存取。
2022年7月,美國知名醫療設備製造商Sharps Technology以250萬美元收購了Safeguard Medical的智慧注射器生產工廠。此次收購旨在擴大Sharps的生產能力,並滿足日益成長的智慧注射器需求。 Safeguard Medical是一家專注於智慧注射器和急救醫療技術的美國製造商,在當前充滿活力的市場環境中,為Sharps Technology的成長策略做出了貢獻。
智慧注射器市場的主要參與者包括 Becton Dickinson and Company、Gerresheimer AG、Baxter International Inc.、Terumo Corporation、Braun Melsungen AG、Cardinal Health Inc.、Smiths Medical Inc.、Retractable Technologies Inc.、AdvaCare Pharma、Numedico Technologies Pty Ltd.、Merit Technology Inc. AG、Vetter Pharma International GmbH、Catalent Inc.、Thermo Fisher Scientific Inc.、Haselmeier GmbH、Owen Mumford Ltd.、Ypsomed Holding AG、威高集團、江蘇匯達醫療器材有限公司及山東威高集團醫用高分子有限公司。
2024年,北美是全球智慧注射器市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。智慧注射器市場報告涵蓋亞太地區、西歐、東歐、北美、南美以及中東和非洲。
智慧注射器市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、英國、美國、義大利和西班牙。
智慧注射器市場包括可替換針頭注射器和固定針頭注射器的銷售。該市場的價值是「工廠門口」價值,即商品製造商或創造者出售的商品的價值,無論是出售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)還是直接出售給最終客戶。該市場中的商品價值還包括商品創造者出售的任何相關服務。
Smart syringes represent cutting-edge medical devices that integrate technology to enhance the safety, precision, and efficiency of administering injections. These innovative syringes effectively address critical concerns such as needlestick injuries, medication errors, and the transmission of bloodborne diseases, thereby significantly improving both patient and healthcare provider safety.
The primary categories of smart syringes include auto-disable syringes, active safety syringes, and passive safety syringes. Auto-disable syringes are specifically engineered to prevent reuse after a single injection. Widely employed in immunization campaigns, these syringes automatically lock after a single use, ensuring the secure and contamination-free delivery of doses. This versatile solution caters to various segments, including pediatrics and adults, and finds applications in drug delivery, vaccination, and blood specimen collection. Auto-disable syringes are utilized across diverse industries, including hospitals, health maintenance organizations (HMOs), diabetic patient care, family practices (physicians), psychiatry, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The smart syringes market research report is one of a series of new reports from The Business Research Company that provides smart syringes market statistics, including smart syringes industry global market size, regional shares, competitors with a smart syringes market share, detailed smart syringes market segments, market trends, and opportunities, and any further data you may need to thrive in the smart syringes industry. These smart syringes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The smart syringe market size has grown strongly in recent years. It will grow from $11.14 billion in 2024 to $12.15 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to need for medication safety, prevalence of blood-borne diseases, regulatory compliance, global immunization programs, increased healthcare awareness.
The smart syringe market size is expected to see rapid growth in the next few years. It will grow to $19.02 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to global vaccination initiatives, prevention of medication errors, rise in chronic diseases, expansion of home healthcare, government healthcare initiatives. Major trends in the forecast period include collaborations and partnerships, regulatory compliance, adoption in vaccination programs, focus on sustainable materials, expansion in emerging markets.
The forecast of 11.9% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on dose-control microprocessors and auto-disable mechanisms, primarily sourced from France and Denmark, increasing costs for safe medication administration systems.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
Increasing healthcare expenditure is anticipated to drive the growth of the smart syringes market in the coming years. Healthcare expenditure represents the total resources, usually quantified in monetary terms, that a country, organization, or individual dedicates to healthcare services and products. This rise in spending is influenced by various factors, including an aging population, the prevalence of chronic diseases, advancements in medical technology, and growing consumer expectations for high-quality care. The smart syringes market aligns with this increased expenditure by offering innovative solutions that enhance patient safety, improve procedural efficiency, and lower healthcare costs related to complications from traditional syringes. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization, projected total health spending in Canada to reach $344 billion for the year, a 2.8% increase over the prior year. Thus, the growth in healthcare expenditure is fueling the expansion of the smart syringes market.
The rising prevalence of blood-borne diseases is expected to drive the growth of the smart syringes market in the coming years. Blood-borne diseases are infections caused by pathogens transmitted through contact with infected blood or bodily fluids. Smart syringes offer an effective tool in combating these diseases, featuring a mechanism that automatically disables the plunger after a single use, thus reducing the risk of accidental needle sticks. For example, in April 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, reported 2,126 acute hepatitis B cases in 2022, equating to an estimated 13,800 infections after accounting for underreporting. This marks an increase from 2021, which had 2,045 reported cases and approximately 13,300 estimated infections. Consequently, the growing prevalence of blood-borne diseases is fueling the expansion of the smart syringes market.
Product innovations are increasingly popular in the smart syringes market, as major companies introduce new products like safety syringes to enhance patient safety, minimize needlestick injury risks, and boost procedural efficiency. Safety syringes are specifically designed to lower the chance of needlestick injuries and prevent syringe reuse. For instance, in April 2024, Hindustan Syringes and Medical Devices, an India-based medical device company, launched Dispojekt Syringes, a safety syringe designed to enhance safety in healthcare settings. Dispojekt features a transparent, one-hand-operable safety mechanism to reduce accidental needlestick injuries (NSIs), a common source of blood-borne disease transmission among healthcare professionals. The syringe also includes a molded plastic safety shield to prevent blood splatter during use, fostering a safer environment for both patients and healthcare workers. By addressing critical safety and infection control concerns, Dispojekt reflects HMD's commitment to quality and innovation, supporting India's goal of becoming a global leader in medical manufacturing.
Companies at the forefront of the smart syringes market are actively investing in technological advancements, incorporating innovations such as Near Field Communication (NFC) technology to gain a competitive advantage. NFC is a short-range wireless communication technology facilitating contactless data exchange between devices. NP Plastibell, a France-based medical device manufacturer, exemplifies this trend with the launch of its Pre-filled Smart Syringe in May 2022. This smart syringe incorporates an embedded NFC chip that transmits essential information about the medication to both practitioners and patients. The NFC chip stores crucial details, including drug name, dosage, expiration date, and lot number, allowing easy access through smartphones or other NFC-enabled devices.
In July 2022, Sharps Technology, a prominent US-based medical device manufacturer, acquired Safeguard Medical's smart syringes manufacturing facility for $2.5 million. This acquisition is aimed at expanding Sharps' manufacturing capabilities to meet the rising demand for smart syringes. Safeguard Medical, a US-based manufacturer specializing in smart syringes and emergency medical technologies, contributes to Sharps Technology's growth strategy in this dynamic market landscape.
Major companies operating in the smart syringe market include Becton Dickinson and Company, Gerresheimer AG, Baxter International Inc., Terumo Corporation, Braun Melsungen AG, Cardinal Health Inc., Smiths Medical Inc, Retractable Technologies Inc., AdvaCare Pharma, Numedico Technologies Pty Ltd., Merit Medical Systems Inc., Nipro Corporation, Revolutions Medical Corporation, Sharps Technology, West Pharmaceutical Services Inc., Schott AG, Vetter Pharma International GmbH, Catalent Inc., Thermo Fisher Scientific Inc., Haselmeier GmbH, Owen Mumford Ltd., Ypsomed Holding AG, Weigao Group, Jiangsu Huida Medical Instruments Co. Ltd., Shandong Weigao Group Medical Polymer Co. Ltd.
North America was the largest region in the global smart syringes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart syringe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the smart syringe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The smart syringes market consists of sales of exchangeable needle syringes and fixed needle syringes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Smart Syringe Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on smart syringe market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for smart syringe ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The smart syringe market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.